P. Masarachia

2.9k citations

22 papers · 2.3k indexed · 1 hit paper · h-index 20

Oncology top 2%
Molecular Biology top 10%
Orthopedics and Sports Medicine top 0.5%
Cellular and Molecular Neuroscience top 10%
Radiology, Nuclear Medicine and Imaging top 10%

Co-authors: Gideon A. Rodan Alfred A. Reszka Gregg Wesolowski James D. Bergstrom Richard G. Bostedor R. Balena A A Reszka Michael J. Rogers
Topics: Bone health and treatments (14 papers)Bone Metabolism and Diseases (9 papers)Bone health and osteoporosis research (8 papers)
Cited by: Orthopedics and Sports Medicine Oncology Molecular Biology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry The Journal of Comparative Neurology
Partner nations: United States Japan United Kingdom

In The Last Decade

P. Masarachia

22 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro

1999 570 citations John Fisher, Michael J. Rogers et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by P. Masarachia

Since Specialization

Citations

This map shows the geographic impact of P. Masarachia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Masarachia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Masarachia more than expected).

Fields of papers citing papers by P. Masarachia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Masarachia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Masarachia. The network helps show where P. Masarachia may publish in the future.

Co-authorship network of co-authors of P. Masarachia

This figure shows the co-authorship network connecting the top 25 collaborators of P. Masarachia. A scholar is included among the top collaborators of P. Masarachia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Masarachia. P. Masarachia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking 2011 ·Bone ·(unknown),Maureen Pickarski,Ya Zhuo,P. Masarachia,Le T. Duong	90
2	Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeys 2011 ·Journal of Bone and Mineral Research ·P. Masarachia,Brenda L Pennypacker,Maureen Pickarski,Kevin R. Scott,Gregg Wesolowski,Susan Y. Smith,(unknown),(unknown),Boyd B. Scott,Donald B. Kimmel,Le T. Duong	95
3	Cathepsin K inhibitors prevent bone loss in estrogen-deficient rabbits 2010 ·Journal of Bone and Mineral Research ·Brenda L Pennypacker,Le T. Duong,(unknown),P. Masarachia,Michael A. Gentile,J. Y. GAUTHIER,W. Cameron Black,Boyd B. Scott,Rana Samadfam,Susan Y. Smith,Donald B. Kimmel	84
4	Bone density, strength, and formation in adult cathepsin K (−/−) mice 2008 ·Bone ·Brenda L Pennypacker,M. Shea,(unknown),P. Masarachia,Paul Säftig,Sevgi B. Rodan,Gideon A. Rodan,Donald B. Kimmel	113
5	Trabecular bone microarchitecture after alendronate treatment of osteoporotic women 2005 ·Current Medical Research and Opinion ·R. R. Recker,P. Masarachia,Arthur C. Santora,Todd K. Howard,Pascale Chavassieux,M. Arlot,Gideon A. Rodan,Lois E. Wehren,Donald B. Kimmel	71
6	Androgenic Induction of Growth and Differentiation in the Rodent Uterus Involves the Modulation of Estrogen-Regulated Genetic Pathways 2004 ·Endocrinology ·Pascale V. Nantermet,P. Masarachia,Michael A. Gentile,Brenda L Pennypacker,Jian Xu,Daniel Holder,David Gerhold,Dwight A. Towler,Azriel Schmidt,Donald B. Kimmel,Leonard P. Freedman,(unknown),William J. Ray	58
7	Alendronate Is a Specific, Nanomolar Inhibitor of Farnesyl Diphosphate Synthase 2000 ·Archives of Biochemistry and Biophysics ·James D. Bergstrom,Richard G. Bostedor,P. Masarachia,Alfred A. Reszka,Gideon A. Rodan	326
8	Bisphosphonates Act Directly on the Osteoclast to Induce Caspase Cleavage of Mst1 Kinase during Apoptosis 1999 ·Journal of Biological Chemistry ·Alfred A. Reszka,(unknown),P. Masarachia,Gideon A. Rodan	216
9	Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitrobreakdown → 1999 ·Proceedings of the National Academy of Sciences ·John Fisher,Michael J. Rogers,(unknown),Steven P. Luckman,(unknown),P. Masarachia,Gregg Wesolowski,R.G.G. Russell,Gideon A. Rodan,A A Reszka	570
10	Comparison of the distribution of 3H-alendronate and 3H-Etidronate in rat and mouse bones 1996 ·Bone ·P. Masarachia,Miron Weinreb,R. Balena,Gideon A. Rodan	205
11	The effects of the aminobisphosphonate alendronate on thyroid hormone-induced osteopenia in rats 1993 ·Calcified Tissue International ·Michiko Yamamoto,A. Markatos,J.G. Seedor,P. Masarachia,Michael A. Gentile,Gideon A. Rodan,R. Balena	26
12	The aminobisphosphonate alendronate inhibits bone loss induced by thyroid hormone in the rat comparison between effects on tibiae and vertebrae 1993 ·Bone ·R. Balena,A. Markatos,Michael A. Gentile,P. Masarachia,J.G. Seedor,Gideon A. Rodan,Michiko Yamamoto	22
13	Gap junctions between the pedicles of macaque foveal cones 1992 ·Vision Research ·Yoshihiko Tsukamoto,P. Masarachia,Stanley J. Schein,Peter Sterling	76
14	Comparison of the therapeutic potencies of two bisphosphonates 1992 ·Bone ·J.G. Seedor,R. Balena,P. Masarachia,Gideon A. Rodan	6
15	Immunoreactivity to GABA_A receptor in the outer plexiform layer of the cat retina 1992 ·The Journal of Comparative Neurology ·Noga Vardi,P. Masarachia,Peter Sterling	65
16	He bisphosphonate alendronate inhibits bone loss induced by thyroid hormone in rats 1992 ·Bone ·R. Balena,Manabu Yamamoto,Michael A. Gentile,P. Masarachia,J.G. Seedor,(unknown)	1
17	Structure of the starburst amacrine network in the cat retina and its association with alpha ganglion cells 1989 ·The Journal of Comparative Neurology ·Noga Vardi,P. Masarachia,Peter Sterling	26
18	An electron microscopic study of terminals of rapidly adapting mechanoreceptive afferent fibers in the cat spinal cord 1985 ·The Journal of Comparative Neurology ·Kazue Semba,P. Masarachia,Sasha Malamed,M Jacquin,Suzan L. Harris,Guoyan Yang,Matthias Egger	48
19	An electron microscopic study of primary afferent terminals from slowly adapting type I receptors in the cat 1983 ·The Journal of Comparative Neurology ·Kazue Semba,P. Masarachia,Sasha Malamed,M Jacquin,Suzan L. Harris,Guoyan Yang,Marcel Egger	65
20	Electron microscopic observations of terminals of functionally identified afferent fibers in cat spinal cord 1981 ·Brain Research ·Marcel Egger,Natalie Freeman,Sasha Malamed,P. Masarachia,Eric Proshansky	21

About P. Masarachia

P. Masarachia is a scholar working on Orthopedics and Sports Medicine, Oncology and Cellular and Molecular Neuroscience, having authored 22 papers that have together received 2.3k indexed citations. Recurring topics across this work include Bone health and treatments (14 papers), Bone Metabolism and Diseases (9 papers) and Bone health and osteoporosis research (8 papers). The work is most often cited by research in Orthopedics and Sports Medicine (893 citations), Oncology (1.3k citations) and Molecular Biology (1.2k citations). P. Masarachia has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Gideon A. Rodan, Alfred A. Reszka, Gregg Wesolowski, James D. Bergstrom, Richard G. Bostedor, R. Balena, A A Reszka, Michael J. Rogers, John Fisher and R.G.G. Russell. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Comparative Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact